The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis
Abstract
The use of lipid nanocapsules (LNCs) has enabled an improvement of the oral bioavailability of paclitaxel (Ptx). However, mechanisms that support this recent observation are not yet understood. By focusing on the well defined in vitro Caco-2 model, the purpose of this study was to evaluate the transport of LNCs across a model intestinal barrier. Firstly, four sizes of paclitaxel or dye (Nile Red)-loaded LNCs were formulated and LNCs with sizes between 26.3+/-2.7 nm and 132.7+/-5.5 nm were obtained. Different transport and uptake experiments were then performed across a Caco-2 cells culture model using these LNCs. Paclitaxel-loaded LNCs improved permeability of Ptx across intestinal epithelium compared with free Ptx or Taxol by a factor of 3.5. At 37 degrees C particle size did not influence transport efficiency. However, at 4 degrees C a decrease in Ptx transport was observed with increasing size of LNCs. Thus, with LNCs of 25 nm size, the apparent permeability coefficient (P(app)) was 5.3+/-1.1 cm s(-1) at 37 degrees C and 2.2+/-0.4 cm s(-1) at 4 degrees C. In comparison in LNCs of 130 nm size, the P(app) decreased from 5.8+/-0.8 cm s(-1) at 37 degrees C to 0.5+/-0.1 cm s(-1) at 4 degrees C. The uptake of LNCs by Caco-2 cells and the incapacity of LNCs to open tight junctions were also demonstrated. Furthermore, experiment transports were performed in the presence of different inhibitors of endocytosis. Findings indicated a reduction of Ptx transport of 30+/-6% when cell cholesterol was depleted, 65+/-12% when caveolae-mediated endocytosis was inhibited and 20+/-8% when clathrin-mediated endocytosis was inhibited. Finally, transmission electronic microscopy showed the presence of nano-objects on the basolateral side of the Caco-2 cell monolayers when LNCs were applied on the apical side.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional rafts in cell membranes
Simons, K., & Ikonen, E. (1997) · Nature · doi:10.1038/42408 · Cited by 9,757 · cited 1×
“The caveolae-dependent or caveolae- and clathrin-independent endocytose are sphingolipid and cholesterol-rich microdomains and are referred to as ‘lipid rafts’ [57].”
BackgroundRegulated portals of entry into the cell
Conner, S. D., & Schmid, S. L. (2003) · Nature · doi:10.1038/nature01451 · Cited by 3,805
Artursson, P., & Karlsson, J. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91647-u · Cited by 1,893
Yin Win, K., & Feng, S.-S. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.07.050 · Cited by 1,452
Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles
Verma, A., Uzun, O., Hu, Y., Hu, Y., Han, H.-S., Watson, N., Chen, S., Irvine, D. J., & Stellacci, F. (2008) · Nature Materials · doi:10.1038/nmat2202 · Cited by 1,266
Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation.
Wang, L. H., Rothberg, K. G., & Anderson, R. G. (1993) · The Journal of cell biology · doi:10.1083/jcb.123.5.1107 · Cited by 1,177
Rodal, S. K., Skretting, G., Garred, Ø., Vilhardt, F., van Deurs, B., & Sandvig, K. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.4.961 · Cited by 1,008
Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size
Desai, M. P., Labhasetwar, V., Amidon, G. L., & Levy, R. J. (1996) · Pharmaceutical Research · doi:10.1023/a:1016085108889 · Cited by 941
Schnitzer, J. E., Oh, P., Pinney, E., & Allard, J. (1994) · The Journal of cell biology · doi:10.1083/jcb.127.5.1217 · Cited by 919
Sparreboom, A., van Asperen, J., Mayer, U., Schinkel, A. H., Smit, J. W., Meijer, D. K. F., Borst, P., Nooijen, W. J., Beijnen, J. H., & van Tellingen, O. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.2031 · Cited by 882
Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots
Lovrić, J., Bazzi, H. S., Cuie, Y., Fortin, G. R. A., Winnik, F. M., & Maysinger, D. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0629-x · Cited by 815
Orlandi, P. A., & Fishman, P. H. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.4.905 · Cited by 722
Lipid nanocapsules: A new platform for nanomedicine
Huynh, N. T., Passirani, C., Saulnier, P., & Benoit, J. P. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.04.026 · Cited by 595
Self-citationJung, T. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00084-9 · Cited by 588
Caco-2 Cell Monolayers as a Model for Drug Transport Across the Intestinal Mucosa
Hilgers, A. R., Conradi, R. A., & Burton, P. S. (1990) · Pharmaceutical Research · doi:10.1023/a:1015937605100 · Cited by 587
A Novel Phase Inversion-Based Process for the Preparation of Lipid Nanocarriers
Heurtault, B., Saulnier, P., Pech, B., Proust, J.-E., & Benoit, J.-P. (2002) · Pharmaceutical Research · doi:10.1023/a:1016121319668 · Cited by 583
Self-citationOptimized conditions for prediction of intestinal drug permeability using Caco-2 cells
Yamashita, S., Furubayashi, T., Kataoka, M., Sakane, T., Sezaki, H., & Tokuda, H. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00076-2 · Cited by 568
Behrens, I., Pena, A. I. V., Alonso, M. J., & Kissel, T. (2002) · Pharmaceutical Research · doi:10.1023/a:1019854327540 · Cited by 372
Gao, P., Rush, B. D., Pfund, W. P., Huang, T., Bauer, J. M., Morozowich, W., Kuo, M., & Hageman, M. J. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10511 · Cited by 361
Preparation and Characterization of Nanoparticles Shelled with Chitosan for Oral Insulin Delivery
Lin, Y.-H., Mi, F.-L., Chen, C.-T., Chang, W.-C., Peng, S.-F., Liang, H.-F., & Sung, H.-W. (2007) · Biomacromolecules · doi:10.1021/bm0607776 · Cited by 349
Transmucosal macromolecular drug delivery
Prego, C., García, M., Torres, D., & Alonso, M. J. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.030 · Cited by 338
Hu, Y., Litwin, T., Nagaraja, A. R., Kwong, B., Katz, J., Watson, N., & Irvine, D. J. (2007) · Nano Letters · doi:10.1021/nl071542i · Cited by 305
Rieux, A. D., Ragnarsson, E. G. E., Gullberg, E., Préat, V., Schneider, Y.-J., & Artursson, P. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.04.015 · Cited by 298
Intestinal Drug Absorption and Metabolism in Cell Cultures: Caco-2 and Beyond
Artursson, P., & Borchardt, R. T. (1997) · Pharmaceutical Research · doi:10.1023/a:1012155124489 · Cited by 280
Cell culture-based models for intestinal permeability: A critique
Balimane, P. V., & Chong, S. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03354-9 · Cited by 278
Peltier, S., Oger, J.-M., Lagarce, F., Couet, W., & Benoît, J.-P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0022-2 · Cited by 274
Self-citationMa, Z., & Lim, L.-Y. (2003) · Pharmaceutical Research · doi:10.1023/b:pham.0000003379.76417.3e · Cited by 265
Polymeric micelles in oral chemotherapy
Bromberg, L. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.01.018 · Cited by 264
Binding and uptake of biodegradable poly-dl-lactide micro- and nanoparticles in intestinal epithelia
McClean, S., Prosser, E., Meehan, E., O'Malley, D., Clarke, N., Ramtoola, Z., & Brayden, D. (1998) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(97)10007-0 · Cited by 260
Engineering of Dendrimer Surfaces to Enhance Transepithelial Transport and Reduce Cytotoxicity
Jevprasesphant, R., Penny, J., Attwood, D., McKeown, N. B., & D'Emanuele, A. (2003) · Pharmaceutical Research · doi:10.1023/a:1026166729873 · Cited by 256
Sha, X., Yan, G., Wu, Y., Li, J., & Fang, X. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.01.001 · Cited by 231
Garcion, E., Lamprecht, A., Heurtault, B., Paillard, A., Aubert-Pouessel, A., Denizot, B., Menei, P., & Benoît, J.-P. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0289 · Cited by 198
Self-citationPolymeric micelles for oral drug delivery: Why and how
Francis, M. F., Cristea, M., & Winnik, F. M. (2004) · Pure and Applied Chemistry · doi:10.1351/pac200476071321 · Cited by 197
Hed, J., Hallden, G., Johansson, S. G. O., & Larsson, P. (1987) · Journal of Immunological Methods · doi:10.1016/0022-1759(87)90224-9 · Cited by 191
The influence of lipid nanocapsule composition on their size distribution
Heurtault, B., Saulnier, P., Pech, B., Venier-Julienne, M.-C., Proust, J.-E., Phan-Tan-Luu, R., & Benoı̂t, J.-P. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00241-5 · Cited by 186
Endocytosis and Interaction of Poly (Amidoamine) Dendrimers with Caco-2 Cells
Kitchens, K. M., Foraker, A. B., Kolhatkar, R. B., Swaan, P. W., & Ghandehari, H. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9415-0 · Cited by 182
Transepithelial and endothelial transport of poly (amidoamine) dendrimers
KITCHENS, K., ELSAYED, M., & GHANDEHARI, H. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.013 · Cited by 177
Malingré, M. M., Beijnen, J. H., & Schellens, J. H. M. (2001) · Investigational New Drugs · doi:10.1023/a:1010635000879 · Cited by 158
Kitchens, K. M., Kolhatkar, R. B., Swaan, P. W., & Ghandehari, H. (2008) · Molecular Pharmaceutics · doi:10.1021/mp700089s · Cited by 157
Nanoparticle strategies for the oral delivery of insulin
Damgé, C., Reis, C. P., & Maincent, P. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.1.45 · Cited by 154
Mi, F., Wu, Y.-Y., Lin, Y.-H., Sonaje, K., Ho, Y., Chen, C.-T., Juang, J.-H., & Sung, H. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800076n · Cited by 146
Cholesterol Depletion of Enterocytes
Hansen, G. H., Niels-Christiansen, L.-L., Thorsen, E., Immerdal, L., & Danielsen, E. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.5136 · Cited by 145
van Amersfoort, E. S., & van Strijp, J. A. G. (1994) · Cytometry · doi:10.1002/cyto.990170404 · Cited by 138
In vitro and in vivo study of N-trimethyl chitosan nanoparticles for oral protein delivery
Chen, F., Zhang, Z., Yuan, F., Qin, X., Wang, M., & Huang, Y. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.07.035 · Cited by 131
Temperature effect on endocytosis and exocytosis by rabbit alveolar macrophages
Tomoda, H., Kishimoto, Y., & Lee, Y. C. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84849-4 · Cited by 116
Gaumet, M., Gurny, R., & Delie, F. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.11.015 · Cited by 115
The gastrointestinal stability of lipid nanocapsules
Roger, E., Lagarce, F., & Benoît, J. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.05.069 · Cited by 113
Self-citationYoo, H. S., & Park, T. G. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10573 · Cited by 110
Crossing cellular barriers using dendrimer nanotechnologies
Najlah, M., & D’Emanuele, A. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.05.004 · Cited by 107
Alternative formulations of paclitaxel
Terwogt, J. M. M., Nuijen, B., Huinink, W. W. T. B., & Beijnen, J. H. (1997) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(97)90022-0 · Cited by 100
Lipid nanocapsules: Ready-to-use nanovectors for the aerosol delivery of paclitaxel
Hureaux, J., Lagarce, F., Gagnadoux, F., Vecellio, L., Clavreul, A., Roger, E., Kempf, M., Racineux, J.-L., Diot, P., & Benoît, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.06.013 · Cited by 100
Self-citationTransport Of Surface‐Modified Nanoparticles Through Cell Monolayers
Koch, A., Reynolds, F., Merkle, H. P., Weissleder, R., & Josephson, L. (2005) · ChemBioChem · doi:10.1002/cbic.200400174 · Cited by 99
Quantum dots for tracking cellular transport of lectin-functionalized nanoparticles
Gao, X., Wang, T., Wu, B., Chen, J., Chen, J.-Y., Yue, Y., Dai, N., Chen, H., & Jiang, X. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.077 · Cited by 85
Caveolin is present in intestinal cells: role in cholesterol trafficking?
Field, F. J., Born, E. J., Murthy, S., & Mathur, S. N. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32492-5 · Cited by 83
Taxol: pharmacology, metabolism and clinical implications.
Rowinsky, E. K., Wright, M., Monsarrat, B., Lesser, G. J., & Rc, D. (1993) · PubMed · Cited by 80
Self-assembled nanoparticles of poly(lactide)–Vitamin E TPGS copolymers for oral chemotherapy
ZHANG, Z., & FENG, S. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.06.013 · Cited by 79
Choi, J. S., & Jo, B.-W. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.05.014 · Cited by 77
Marzesco, A., Wilsch‐Bräuninger, M., Dubreuil, V., Janich, P., Langenfeld, K., Thiele, C., Huttner, W. Β., & Corbeil, D. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.01.048 · Cited by 64
Zha, L., Xu, Z., Wang, M. ‐., & Linbo, G. U. (2007) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/j.1439-0396.2007.00718.x · Cited by 63
Binding and Uptake of Wheat Germ Agglutinin-Grafted PLGA-Nanospheres by Caco-2 Monolayers
Weissenböck, A., Bogner, E., Wirth, M., & Gabor, F. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000045247.09724.26 · Cited by 61
Lochner, N., Pittner, F., Wirth, M., & Gabor, F. (2003) · Pharmaceutical Research · doi:10.1023/a:1023406224028 · Cited by 53
Kapitza, S. B., Michel, B. R., van Hoogevest, P., Leigh, M. L. S., & Imanidis, G. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.08.010 · Cited by 52
Cellular Uptake Study of Biodegradable Nanoparticles in Vascular Smooth Muscle Cells
Suh, H., Jeong, B., Liu, F., & Kim, S. W. (1998) · Pharmaceutical Research · doi:10.1023/a:1011982428413 · Cited by 47
Cited by
The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles
Fröhlich, E. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s36111 · Cited by 2,484
Oral delivery of anticancer drugs: Challenges and opportunities
Thanki, K., Gangwal, R. P., Sangamwar, A. T., & Jain, S. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.020 · Cited by 499
Xin, H., Jiang, X., Gu, J., Sha, X., Chen, L., Law, K., Chen, Y., Wang, X., Jiang, Y., & Fang, X. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.044 · Cited by 384
BCS class IV drugs: Highly notorious candidates for formulation development
Ghadi, R., & Dand, N. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.014 · Cited by 361
Endocytosis of Gene Delivery Vectors: From Clathrin-dependent to Lipid Raft-mediated Endocytosis
El-Sayed, A., & Harashima, H. (2013) · Molecular Therapy · doi:10.1038/mt.2013.54 · Cited by 345
Metadata
- Authors
- Roger, E., Lagarce, F., Garcion, E., & Benoit, J.-P.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 140
- Issue
- 2
- Pages
- 174-181
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2028309493
- Cited by
- 265
- References
- 63
- FWCI
- 12.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.